Foghorn Therapeutics Inc (FHTX)
EBITDA Margin
-170.00%
TTM · Period ending:
FHTX EBITDA Margin
Latest reported-170.00%period ending
Latest reported-170.00%period ending
FHTX TTM EBITDA Margin (-34358.10% → -170.00%)
TTM ebitda margin
High-resolution chart · PNG
FHTX ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -170.0019% | |
| -257.1606% | |
| -229.548% | |
| -280.7366% | |
| -298.7755% | |
| -334.3303% | |
| -374.9889% | |
| -342.0772% | |
| -232.0165% | |
| -253.3072% | |
| -265.6976% | |
| -299.4136% | |
| -504.9342% | |
| -526.3957% | |
| -548.9963% | |
| -669.0994% | |
| -1,148.2322% | |
| -2,030.3251% | |
| -7,340.182% | |
| -10,359.86% | |
| -8,238.593% | |
| -10,532.5419% | |
| -15,463.7209% | |
| -34,358.1006% |